$SANA SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Bishop Hans Edgar, Director Received 8,680 shares as a grant or award
08 Sep 2026	8-K: Regulation FD Disclosure This presentation contains forward-looking statements about Sana Biotechnology, Inc. (the “Company,” “we,” “us,” or “our”) within the meaning of the federal securities laws. All statements other than statements of historical facts contai...
27 Aug 2026	Form 4: Patel Dhavalkumar Dhirajlal, EVP, Chief Scientific Officer Received 125,000 shares by exercise or conversion · Gave up 41,158 shares to cover exercise price or tax ($169K)
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	10-Q
10 Aug 2026	8-K: Results of Operations and Financial Condition
07 Jul 2026	Form 4: Bishop Hans Edgar, Director Received 6,297 shares as a grant or award
05 Jun 2026	Form 4: Yang Patrick Y, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Seitz Michelle, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Reicin Alise, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Rosiello Robert L., Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Mulligan Richard, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Bishop Hans Edgar, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Bilenker Joshua H., Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Nelsen Robert, Director Granted 90,000 Stock Option (Right to Buy)
05 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
21 May 2026	SCHEDULE 13G
15 May 2026	8-K: Other Events
11 May 2026	S-8
11 May 2026	10-Q

Comments